Researchers reviewed how artificial intelligence (AI) is being used to manage prostate cancer. The review looked at how AI models combine imaging, pathology, and clinical data to help doctors identify and grade tumors more accurately. These tools aim to make the diagnostic process faster and reduce differences in judgment between different medical professionals.
In terms of treatment, AI is being explored to improve surgical procedures, radiation therapy, and the development of targeted drugs. By identifying biological indicators, these technologies could help doctors create more personalized plans for each patient. The goal of using AI is to reduce the workload on staff while improving the overall quality of care.
However, it is important to note that most of these AI models are not yet used in everyday clinical practice. Current technology still has limitations that prevent widespread use at this time. While the results show promise for future improvements in accuracy and efficiency, these tools are currently more of a developing technology than a standard current treatment.
